Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -16.450% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCCCOc1ccc(CSCCNC(=S)Nc2ccccc2)cc1
(b) CCCN(CC(=O)Nc1ccccc1Br)CC(=O)Nc1ccc(F)c(F)c1F
Answer: b. CCCN(CC(=O)Nc1ccccc1Br)CC(=O)Nc1ccc(F)c(F)c1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCN(CC(=O)Nc1ccccc1Br)CC(=O)Nc1ccc(F)c(F)c1F
CCCN(CC(=O)Nc1ccccc1Br)CC(=O)Nc1ccc(F)c(F)c1F
N-(2-bromophenyl)-2-[[2-oxo-2-(2,3,4-trifluoroanilino)ethyl]-propylamino]acetamide